Do These 3 Checks Before Buying Winner Medical Co., Ltd. (SZSE:300888) For Its Upcoming Dividend
Do These 3 Checks Before Buying Winner Medical Co., Ltd. (SZSE:300888) For Its Upcoming Dividend
Winner Medical Co., Ltd. (SZSE:300888) stock is about to trade ex-dividend in 3 days. Typically, the ex-dividend date is one business day before the record date which is the date on which a company determines the shareholders eligible to receive a dividend. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn't show on the record date. In other words, investors can purchase Winner Medical's shares before the 4th of June in order to be eligible for the dividend, which will be paid on the 4th of June.
Winner Medical Co., Ltd.(深圳證券交易所股票代碼:300888)股票即將在3天后進行除息交易。通常,除息日是記錄日期前一個工作日,即公司確定有資格獲得股息的股東的日期。除息日是需要注意的重要日期,因爲在該日或之後購買的任何股票都可能意味着延遲結算,而結算日期並未顯示在記錄日期。換句話說,投資者可以在6月4日之前購買Winner Medical的股票,以便有資格獲得股息,股息將於6月4日支付。
The company's upcoming dividend is CN¥0.50 a share, following on from the last 12 months, when the company distributed a total of CN¥0.50 per share to shareholders. Last year's total dividend payments show that Winner Medical has a trailing yield of 1.7% on the current share price of CN¥29.96. If you buy this business for its dividend, you should have an idea of whether Winner Medical's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
該公司即將派發的股息爲每股0.50元人民幣,此前該公司向股東共分配了每股0.50元人民幣。去年的股息支付總額顯示,Winner Medical的尾隨收益率爲1.7%,而目前的股價爲29.96元人民幣。如果你收購這家企業是爲了分紅,你應該知道Winner Medical的股息是否可靠和可持續。這就是爲什麼我們應該經常檢查股息支付是否可持續,以及公司是否在增長。
Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. It paid out 77% of its earnings as dividends last year, which is not unreasonable, but limits reinvestment in the business and leaves the dividend vulnerable to a business downturn. We'd be concerned if earnings began to decline. A useful secondary check can be to evaluate whether Winner Medical generated enough free cash flow to afford its dividend. It paid out an unsustainably high 209% of its free cash flow as dividends over the past 12 months, which is worrying. Unless there were something in the business we're not grasping, this could signal a risk that the dividend may have to be cut in the future.
股息通常從公司收益中支付。如果一家公司支付的股息超過其利潤,那麼分紅可能是不可持續的。它去年將收益的77%作爲股息支付,這並非不合理,但限制了對業務的再投資,使股息容易受到業務衰退的影響。如果收益開始下降,我們會感到擔憂。一項有用的輔助檢查可以用來評估Winner Medical是否產生了足夠的自由現金流來支付其股息。在過去的12個月中,它以股息的形式支付了其自由現金流的209%,這令人擔憂。除非業務中存在一些我們不了解的地方,否則這可能預示着將來可能必須削減股息的風險。
Winner Medical does have a large net cash position on the balance sheet, which could fund large dividends for a time, if the company so chose. Still, smart investors know that it is better to assess dividends relative to the cash and profit generated by the business. Paying dividends out of cash on the balance sheet is not long-term sustainable.
Winner Medical在資產負債表上確實有大量的淨現金狀況,如果公司願意,這可以暫時爲巨額股息提供資金。儘管如此,聰明的投資者知道,最好根據業務產生的現金和利潤來評估股息。在資產負債表上用現金支付股息是不可持續的。
While Winner Medical's dividends were covered by the company's reported profits, cash is somewhat more important, so it's not great to see that the company didn't generate enough cash to pay its dividend. Cash is king, as they say, and were Winner Medical to repeatedly pay dividends that aren't well covered by cashflow, we would consider this a warning sign.
儘管Winner Medical的股息由公司報告的利潤支付,但現金更爲重要,因此,看到該公司沒有足夠的現金來支付股息並不是一件好事。正如他們所說,現金爲王,如果Winner Medical反覆支付現金流無法充分覆蓋的股息,我們會認爲這是一個警告信號。
Click here to see the company's payout ratio, plus analyst estimates of its future dividends.
點擊此處查看該公司的派息率,以及分析師對其未來股息的估計。
![historic-dividend](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240531/0-21627a3790b1a8a65fe73d84be6a866d-0-be1a9d0c6c6ca42ed5e4fcee005b8a39.png/big)
Have Earnings And Dividends Been Growing?
收益和股息一直在增長嗎?
Businesses with shrinking earnings are tricky from a dividend perspective. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. So we're not too excited that Winner Medical's earnings are down 4.1% a year over the past five years.
從股息的角度來看,收益萎縮的企業很棘手。如果業務陷入低迷並削減股息,該公司的價值可能會急劇下降。因此,我們對Winner Medical在過去五年中每年下降4.1%的收入並不感到興奮。
The main way most investors will assess a company's dividend prospects is by checking the historical rate of dividend growth. Winner Medical has seen its dividend decline 27% per annum on average over the past three years, which is not great to see. While it's not great that earnings and dividends per share have fallen in recent years, we're encouraged by the fact that management has trimmed the dividend rather than risk over-committing the company in a risky attempt to maintain yields to shareholders.
大多數投資者評估公司股息前景的主要方式是查看歷史股息增長率。在過去三年中,Winner Medical的股息平均每年下降27%,這並不令人滿意。儘管近年來每股收益和股息下降並不好,但令我們感到鼓舞的是,管理層削減了股息,而不是冒險過度投入公司來維持股東收益率。
To Sum It Up
總結一下
Is Winner Medical an attractive dividend stock, or better left on the shelf? Winner Medical had an average payout ratio, but its free cash flow was lower and earnings per share have been declining. It's not that we think Winner Medical is a bad company, but these characteristics don't generally lead to outstanding dividend performance.
Winner Medical是有吸引力的股息股票,還是最好留在貨架上?Winner Medical的派息率爲平均水平,但其自由現金流較低,每股收益一直在下降。並不是說我們認爲Winner Medical是一家糟糕的公司,但這些特徵通常不會帶來出色的股息表現。
With that being said, if you're still considering Winner Medical as an investment, you'll find it beneficial to know what risks this stock is facing. Case in point: We've spotted 2 warning signs for Winner Medical you should be aware of.
話雖如此,如果你仍在考慮將Winner Medical作爲一項投資,你會發現了解這隻股票面臨哪些風險是有益的。一個很好的例子:我們已經發現了Winner Medical的兩個警告信號,你應該注意了。
If you're in the market for strong dividend payers, we recommend checking our selection of top dividend stocks.
如果您在市場上尋找強勁的股息支付者,我們建議您查看我們精選的頂級股息股票。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。